Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accredited, admin, appeal, bid, biopharmaceutical, California, Carlton, CDIC, CODM, collectability, computed, computer, Concurrently, consummated, contractor, correlation, corroborated, Court, cure, deficiency, delisting, department, distributor, eliminated, entry, EPS, equate, evidence, experienced, extend, FDIC, Federal, Francisco, furnishing, grace, hierarchy, identical, inducement, input, institutional, IntegraSyn, intercompany, interocular, invoiced, issuable, ISSUER, lab, lack, lieu, lowest, Maker, mix, monitor, multicenter, notice, notify, notifying, observability, observable, obsolete, optimistic, order, Panel, political, power, priority, quoted, reclassification, reclassified, redundant, regain, regular, relevant, role, San, segregation, short, South, steady, stem, Suite, Sweetnam, synthesizing, thereof, turnover, Unadjusted, uncollectable, uninsured, unobservable, unrealized, unregistered, Unrestricted, valuation, volume, written
Removed:
accurate, added, addressing, agent, apparent, audit, base, bearing, building, bullosa, calculation, cannabinol, chartered, closely, Committee, commodity, communication, component, CONCENTRATION, conduct, contractual, convertible, counter, damage, denominated, enrollment, equivalent, escrow, exercised, expanded, expire, extensive, factor, floating, flow, fluctuate, focusing, forfeiture, gain, group, holding, inclusion, incurring, instrument, IntegraSynTM, invest, investing, liquidity, loan, maintained, managing, Nil, organization, oversee, patient, periodically, policy, proportionally, recoverability, recoverable, redeemed, relation, relief, reputable, reputation, requisite, respond, risking, Science, selection, settle, Simplified, statement, stressed, study, symptomology, toxicology, transparent, unacceptable, undiscounted, VWAP
Filing tables
Filing exhibits
INM similar filings
Filing view
External links
Exhibit 32.2
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Jonathan Tegge, the Chief Financial Officer of InMed Pharmaceuticals Inc. (the “Company”), hereby certify that, to my knowledge:
1. | The Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 13, 2023
/s/ Jonathan Tegge | ||
Name: | Jonathan Tegge | |
Title: | Interim Chief Financial Officer |